{"id":"W4282981679","doi":"10.1158/1538-7445.am2022-ct185","title":"Abstract CT185: A phase I dose escalation study of a tegavivint (BC2059) a first-in-class TBL1 inhibitor for patients with progressive, unresectable desmoid tumors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Familial adenomatous polyposis; Internal medicine; Cmin; Gastroenterology; Nuclear medicine; Cancer; Surgery; Pharmacokinetics; Cmax; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009643091,0.0002051503,0.0005122174,0.0005485642,0.0004460987,0.00002414336,0.000192204,0.00003454474,0.0003577129],"category_scores_gemma":[0.0005786946,0.000170449,0.00006084694,0.001422106,0.0002087903,0.0001202404,0.0002701283,0.0006354374,0.000003133978],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001002967,"about_ca_system_score_gemma":0.0005829645,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001203884,"about_ca_topic_score_gemma":0.001159657,"domain_scores_codex":[0.9965429,0.0001487455,0.0004734051,0.0005621127,0.001587842,0.0006850314],"domain_scores_gemma":[0.9979432,0.0004680774,0.0001730982,0.0004198703,0.000830238,0.0001655152],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0336621,0.02386981,0.9090696,0.001552546,0.0004075256,0.0008841097,0.01462393,0.000448153,0.003077029,0.00002291122,0.004098852,0.008283443],"study_design_scores_gemma":[0.0809239,0.04688618,0.8321412,0.001401557,0.0001750036,0.00002524855,0.02838059,0.0005237834,0.005399237,0.00008007243,0.003483149,0.000580037],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915962,0.0006549645,0.000001560425,0.0003160898,0.00009054022,0.007013084,0.0001328582,0.00003785375,0.000156821],"genre_scores_gemma":[0.9898801,0.000009498836,0.00006884207,0.00001475823,0.0001192064,0.009552021,0.000046274,0.00006193071,0.0002473982],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07692835,"threshold_uncertainty_score":0.6950706,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06401263804924762,"score_gpt":0.413709845570424,"score_spread":0.3496972075211764,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}